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Background: How the initial infusion rate of glucose solution should be set to avoid hyperglycemia in the
perioperative setting is unclear.
Methods: Computer simulations were performed based on data from seven studies where the kinetics of glucose
was calculated using a one-compartment model. Glucose had been infused intravenously on 44 occasions to
volunteers and on 256 occasions to surgical patients at various stages of the perioperative process. The rates that
yield plasma glucose concentrations of 7, 9, and 12 mmol/l were calculated and standardized to a 5 % glucose
solution infused in a subject weighing 70 kg.
Results: The lowest infusion rates were found during surgery and the first hours after surgery. No more than
0.5 ml/min of glucose 5 % could be infused if plasma glucose above 7 mmol/l was not allowed, while 2 ml/min
maintained a steady state concentration of 9 mmol/l. Intermediate infusion rates could be used in the preoperative
period and 1–2 days after moderate-sized surgery (e.g., hysterectomy or hip replacement). Here, the half-lives
averaged 30 min, which means that plasma glucose would rise by another 25 % if a control sample is taken 1 h
after a continuous infusion is initiated. The highest infusion rates were found in non-surgical volunteers, where
8 ml/min could be infused before 9 mmol/l was reached.
Conclusions: Computer simulations suggested that rates of infusion of glucose should be reduced by 50 % in the
perioperative period and a further 50 % on the day of surgery in order to avoid hyperglycemia.
Keywords: Blood glucose, Metabolism glucose, Pharmacokinetics, Hyperglycemia
Background
Intravenous glucose is the hallmark of maintenance fluid
therapy to prevent starvation and provide free water for
intracellular hydration. However, practices differ regard-
ing its use in the perioperative period. Oral intake is the
recommended type of carbohydrate administration in
routine patients, but various reasons may call for the use
of intravenous glucose both before and after surgery.
Providing intravenous glucose carries the risk of inducing
hyperglycemia, which promotes postoperative infection
(Hahn and Hahn 2011; Sieber et al. 1987; Kwon et al.
2013; Frisch et al. 2010; Hanazaki et al. 2009; Lipshutz
and Gropper 2009) and osmotic diuresis (Doze and White
1987). Very high glucose concentrations lead to more
pronounced cerebral damage in the event of cardiac arrest
(Myers and Yamaguchi 1977; Siemkowicz 1985).
Infusion rates that provide effective fluid and nutritional
support therapy while avoiding hyperglycemia might be
difficult to determine in the perioperative setting, as glu-
cose turnover becomes impaired as part of the trauma re-
sponse (Ljunggren et al. 2014a). Plasma glucose should be
measured to guide adjustments of the infusion rate, but
the point at which the check best reflects the risk of
hyperglycemia is unclear to most clinicians.
The aim of the present work was to predict how fast
glucose can be infused to reach specific concentrations
of plasma glucose at defined points in time during the
perioperative period in non-diabetic patients. These
rates may serve as approximations of how initial infusion
rates should be set, depending on the level to which the
plasma glucose can be allowed to rise.
The hypothesis was that infusion rates should be
reduced by at least 50 % as compared to healthy humans
during and after surgery. To indicate the degree by whichCorrespondence: Robert.hahn@sodertaljesjukhus.se
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the rates should be modified, computer simulations were
performed based on kinetic data from seven previous
studies of glucose administration performed at various
stages of the perioperative period (Sjöstrand and Hahn
2003; Hahn et al. 2011; Hahn et al. 2013; Ljunggren and
Hahn 2012; Sjöstrand and Hahn 2004; Sicardi Salomón et
al. 2006; Strandberg and Hahn 2005).
Methods
This study is based on 321 infusion experiments, per-
formed between 2002 and 2012, in which glucose was
administered by intravenous infusion. The subjects were
26 volunteers and 161 patients in various stages of the
perioperative process. All subjects gave their consent for
participation after being informed about the purpose of the
study. The results have been published in seven previous
reports (Sjöstrand and Hahn 2003; Hahn et al. 2011; Hahn
et al. 2013; Ljunggren and Hahn 2012; Sjöstrand and Hahn
2004; Sicardi Salomón et al. 2006; Strandberg and Hahn
2005). Four of them excluded patients with any disease
(Sjöstrand and Hahn 2003; Hahn et al. 2011; Sjöstrand and
Hahn 2004; Strandberg and Hahn 2005), and three
excluded patients with disease of importance to glucose
and fluid turnover (Hahn et al. 2013; Ljunggren and Hahn
2012; Sicardi Salomón et al. 2006).
Ethics
The appropriate Ethics Committee approved the protocol
for each of the studies. These were the Ethics Committee
of Huddinge Hospital (Sjöstrand and Hahn 2003;
Sjöstrand and Hahn 2004; Strandberg and Hahn 2005)
and, later, the Regional Ethics Committee of Stockholm
(Hahn et al. 2011; Hahn et al. 2013; Ljunggren and Hahn
2012; Sicardi Salomón et al. 2006). The approval numbers
and the dates of decision were 258/00 (June 5, 2000)
(Sjöstrand and Hahn 2003), 2007/1670-31 (January 30,
2008) (Hahn et al. 2011), 2011/1141-31/3 (September 28,
2011) (Hahn et al. 2013), 2008/1691-31/4 (September 28,
2011) (Ljunggren and Hahn 2012), 429/97 (January 12,
1998) (Sjöstrand and Hahn 2004), 19/03 (February 11,
2003) (Sicardi Salomón et al. 2006) and 34/99 (March 29,
1999) (Strandberg and Hahn 2005). The chairpersons
were Lennart Kaijser (Sjöstrand and Hahn 2003; Sjöstrand
and Hahn 2004; Strandberg and Hahn 2005), Hans
Glaumann (Sicardi Salomón et al. 2006), Olof Forssberg
(Hahn et al. 2011), Håkan Julius (Hahn et al. 2013), and
Annika Marcus (Ljunggren and Hahn 2012).
Procedures and measurements
All subjects were in the fasting state, which means that
no food or sugar-containing beverages had been ingested
for at least 4 h. Experiments started in the morning, and
the only fluid given was a solution containing glucose
2.5 % (Sjöstrand and Hahn 2003; Sjöstrand and Hahn
2004; Sicardi Salomón et al. 2006; Strandberg and Hahn
2005) or 30 % (Hahn et al. 2011; Hahn et al. 2013;
Ljunggren and Hahn 2012). The fluid with the low
glucose concentration was buffered and half-isotonic
with regard to electrolytes (sodium 70, chloride 45, and
acetate 25 mmol/l), while the other solution contained
only glucose. Infusion times varied between 1 and 80 min,
and the total amount of glucose was usually between 200
and 300 mg/kg (Table 1). General anesthesia was used in
the patients where the glucose kinetics was studied during
ongoing surgery. Pain relief was enhanced by thoracic
epidural anesthesia in nine of these patients who under-
went major abdominal surgery.
Plasma glucose concentrations in venous blood were
measured on 7–20 occasions, using the glucose oxidase
method. Duplicate samples were usually drawn at base-
line and ensured a coefficient of variation of 1.2–1.5 %.
Calculations
Kinetic analyses and simulations were made according to
a one-compartment model implemented in MATLAB 4.2
(MathWorks Inc., Natick, MA). Simulations employed
mean and individual data from the seven studies to pre-
dict the infusion rates required to reach and to maintain
each one of three predetermined concentrations of plasma
glucose (7, 9, and 12 mmol/l). The infusion rates required
to reach these targets within 30 min were also calculated.
The equations used are specified in the Appendix.
Insulin resistance was estimated by the Homeostatic
Model Assessment of Insulin Resistance (HOMA-IR),
which was the product of the plasma concentrations of
glucose (mmol/l) and insulin (pmol/) just before the
infusion started (Ljunggren and Hahn 2012). These data
were available in all studied except one (Sicardi Salomón
et al. 2006). No correction for units was made, but
HOMA-IR was 10log-transformed to obtain a linear
correlation with the hyperinsulinemic glucose clamp
(Borai et al. 2007; Ljunggren et al. 2014b).
Data are presented as the means (standard deviation).
Results
The characteristics of the studied cohorts are presented
in Table 1. Twenty-one experiments were excluded
because of incomplete data, leaving 300 experiments to
be included in the final analysis.
Plasma glucose from representative series of experiments
is shown in Fig. 1.
The volume of distribution (Vd), clearance (CL), and
HOMA-IR for each study group is shown in Table 1.
The infusion rates of glucose 5 % predicted to reach
and maintain steady state levels of 7, 9, and 12 mmol/l
in a subject weighing 70 kg based on each experiment
separately are illustrated graphically in Fig. 2 and also
given in Table 2, left.
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Healthy volunteers 44 29 (7) 73 (14) 8/18c 0.25–0.62 5.0 (0.4) 35 (23) 2.15 (0.33) 164 (74) 8.7 (3.4) 15 (8) Sjöstrand and
Hahn (2003);
Hahn et al. (2011)
1 day before hip
replacement surgery















9 69 (6) 63 (11) 4/5 ≈0.20 5.7 (1.1) – – 190 (34) 1.5 (0.7) 110 (67) Sicardi Salomón
et al. (2006)d
2–3 h after hip
replacement surgery
60 68 (9) 83 (15) 41/9 0.20 5.9 (1.1) 47 (28) 2.35 (0.34) 174 (34) 3.3 (0.9) 38 (11) Ljunggren and
Hahn (2012)
1 day after hip
replacement surgery





15 50 (5) 70 (9) 15/0 0.31 6.2 (0.7) 35 (16) 2.28 (0.25) 147 (41) 6.1 (1.2) 17 (5) Strandberg and
Hahn (2005)
aThe 10log of (P-glucose × P-insulin). For crude HOMA-IR, the product should be divided by 156 to correct for units (22.5 if insulin is reported in mU l−1) where 1 = normal
bThe half-life was obtained as 0.693 Vd/CL
cSix males underwent four experiments each











The infusion rates required to reach 7, 9, and 12 mmol/l
within 30 min are shown in Table 2, right. After 30 min,
each concentration can be maintained by reducing the
rate of infusion to the one shown in Table 2, left. In all
groups, the appropriate reduction is to 50–70 % of the
rates needed to obtain the concentration (Fig. 3a).
HOMA-IR correlated poorly with the kinetic parame-
ters obtained during the infusion experiments and also
with the simulated maximum infusion rates (Fig. 3b–e).
Discussion
Limits for the infusion rate of intravenous glucose are
warranted, as studies demonstrate that, otherwise, patients
are at risk of becoming markedly hyperglycemic (Sieber et
al. 1987; Doze and White 1987). The consequences are
dependent on the duration of the hyperglycemia and
become worse in diabetics. Plasma glucose >10 mmol/l
clearly increases the risk of postoperative infection, but
there is also a higher likelihood of acute renal failure and
death (Kwon et al. 2013; Frisch et al. 2010; Hanazaki et al.
2009; Lipshutz and Gropper 2009). Osmotic diuresis
develops when plasma glucose is 12–15 mmol/l, which
implies that the kidneys lose control of the fluid and
electrolyte excretion.
The infusion rates suggested here are intended to be a
guide for how to begin intravenous glucose therapy if
hyperglycemia is to be avoided. They are calculated for
glucose 5 %. Anesthetists who use glucose 2.5 % simply
double the rates.
Main results
The results show that the anesthetist has to consider at
least a fourfold modification in infusion rate of glucose
solution to account for the fact that hyperglycemia
develops more easily in conjunction with surgery.
The infusion rates were clustered in three groups. The
lowest were found during surgery and during the first
hours after surgery (Table 2). Here, the calculated rates
required to avoid plasma glucose >7 mmol/l were so low
(0.5–1.5 ml/min) that providing glucose in this setting
is hardly meaningful. A 1-l bag of glucose 5 % would
need to be administered over 11–33 h to avoid hyper-
glycemia. In contrast, a rate of infusion of 2 ml/min
would be possible if plasma glucose of 9 mmol/l was
acceptable. That corresponds to an infusion time of 8 h
for a 1-l bag.
The intermediate rates are found in the preopera-
tive period and 2 days after surgery. Here, plasma
glucose of 7 mmol/l could still easily be exceeded, if
9 mmol/l would be acceptable, glucose could be in-
fused twice as fast as during surgery (1 l over 4 h).
Finally, glucose can apparently be given to healthy in-
dividuals at an even higher rate without causing
hyperglycemia.
Another way to administer glucose is by using a two-
step strategy consisting of a more rapid initial infusion
after which the rate is reduced to maintain a predeter-
mined steady-state concentration. In the present series
of simulations, we used 30 min as a reasonable time
Fig. 1 Examples of plasma glucose-time curves. Individual subjects (thin lines) and the modeled curve based on the mean values of the kinetic
parameters Vd and CL (thick line). a is based on data from Sjöstrand and Hahn (2003), b from Sicardi Salomón et al. (2006), c original figure from
Hahn et al. (2013), and d re-written based on data from Strandberg and Hahn (2005)
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period for glucose loading. Most of the study groups
would require quite similar amounts of glucose to raise
the plasma glucose level—approximately 2–3 ml/min to
increase the concentration to 7 mmol/l within 30 min in
a subject weighing 70 kg. Most of the variability in infu-
sion rates depicted in Table 2, right, is due to differences
in baseline glucose, while between-patient differences in
glucose kinetics become more apparent when attempting
to maintain steady state.
A practical question is at which point in time a control
blood sample should be taken when a check for hypergly-
cemia is desired in an individual patient. Such information
is possible to derive from the half-lives given in Table 1.
For a continuous infusion, half of the increase in plasma
glucose takes place after one half-life, which is roughly
30 min in less stressful surgery such as laparoscopic chole-
cystectomy. As the final steady state takes about four half-
lives to reach, the clinician would have to wait as long as
2–2.5 h until the maximum plasma glucose concentration
is obtained. Therefore, a useful approach would be to take
a control sample after 1 h, which roughly corresponds to
two half-lives in the perioperative setting, and to consider
that then the plasma glucose will increase by another 25 %
if no adjustment to the infusion rate is made. This simple
rule does not seem to be useful during open abdominal
surgery as the half-life is much longer and also associated
with greater variability.
Limitations due to the studied cohorts
The patients included in this report are representative for
a large proportion of the surgical population, while the
suitable infusion rates may possibly be different in
younger subjects and in special conditions. The studied
patients were all in good health, which is an ethical
requirement since the protocols involved volume loading
that expanded the plasma volume by 10–15 %. No previ-
ous study has been performed which suggests suitable
initial infusion rates for glucose in these groups of
patients. The lack is probably explained by a well-spread
belief that each patient must be evaluated individually
because the plasma glucose responses to glucose infusions
vary too much. Therefore, the existing literature offers
surprisingly little guidance on this topic. However, the
cohorts shown in Fig. 1 illustrate that the between-patient
variation in plasma glucose is quite small in the periopera-
tive period and that very good predictions can be made by
taking the modeled average parameter values in a one-
compartment model (thick blue lines) represent the
individual plasma concentrations (thin red lines).
Open abdominal surgery was the only exception to this
rule. The marked variability in the plasma glucose re-
sponses to exogenous glucose in this group could possibly
be explained by variable efficiency of the thoracic epidural
anesthesia to block the trauma response. In any event,
repeated measurements of plasma glucose are warranted to
guide glucose therapy if needed during this type of surgery.
Patients with diabetes, sepsis, and steroid treatment
also need more individualized glucose administration
and monitoring. Naturally, non-diabetic patients who
receive intravenous insulin require much larger amounts
of glucose than indicated here (Berndtson et al. 2008).
The glucose metabolism shows that circadian rhythm
responses may be greater to feeding during the dark
period of the day (Kalsbeek et al. 2014).
Insulin resistance and HOMA-IR
Insulin resistance is the key mechanism for the slowing
of glucose turnover during and after surgery (Ljunggren
Fig. 2 Rates of infusion of glucose 5 % required to maintain plasma
glucose concentrations (steady state) of 7, 9, and 12 mmol/l during the
perioperative period, standardized to a body weight of 70 kg. The
mean age of each group is shown on top of the bottom columns
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et al. 2014a). Inactivity-induced impairment of cardiore-
spiratory fitness can induce some degree of insulin resist-
ance even before surgery (Larsen et al. 2012). Another
mechanism that raises plasma glucose is increased
gluconeogenesis caused by psychological stress and
surgical trauma. In our kinetic model, the summary
effect of all these factors consists in a reduction of CL
and a slightly raised plasma glucose concentration at
baseline (Table 1).
The HOMA-IR did not reveal great differences between
the groups and was of little or no help as a guide to the
choice of infusion rates that avoid hyperglycemia. The
HOMA-IR indicates insulin resistance as measured by the
hyperinsulinemic glucose clamp in the “unstressed” state
(Borai et al. 2007). However, HOMA-IR reflects hepatic
insulin resistance (Borai et al. 2007) and recent evidence
shows an increase by only 3–4 % in response to surgery
(Ljunggren and Hahn 2012; Ljunggren et al. 2014b). In
contrast, both the CL and the glucose clamp are strongly
influenced by peripheral (skeletal muscle) insulin resist-
ance, which might be doubled (Ljunggren et al. 2014a).
Therefore, HOMA-IR only reflects the insulin resistance
before surgery is undertaken and can be taken as an index
of the effect of age and poor cardiorespiratory fitness on
the glucose disposal. The studied patient groups varied in
age, but only the volunteers (mean age 29 years) had a
Fig. 3 a Rates of infusion of glucose 5 % required to obtain a glucose concentration of 7, 9, and 12 mmol/l and the rates required to maintain
this plasma concentration. Each data point is the mean value for one of the groups shown in Table 2. b, c Poor correlation between HOMA-IR
and the disposition of glucose when infused intravenously. d, e Variability in the relationship between the CL and recommended rates of infusion.
In subplots B to E, each point represents one infusion experiment
Table 2 Rates of infusion of glucose 5 % required for reaching various predetermined target steady-state concentrations of plasma
glucose (left) and rates of infusion required to reach the target within 30 min (right)
Study group Infusion rate (ml/min) at steady state Infusion rate (ml/min) to reach target after 30 min
7 mmol/l 9 mmol/l 12 mmol/l 7 mmol/l 9 mmol/l 12 mmol/l
Healthy volunteers 4.5 (2.1) 8.9 (3.7) 15.5 (6.2) 5.7 (2.6) 11.3 (4.3) 19.7 (7.1)
1 day before hip replacement surgery 2.1 (1.2) 4.5 (1,9) 8.1 (3.3) 3.7 (1.5) 7.8 (2.0) 14.0 (2.8)
During hernia surgery 0.6 (0.2) 1.6 (0.3) 3.0 (0.5) 2.3 (0.9) 5.7 (1.4) 10.9 (2.3)
During laparoscopic cholecystectomy 1.4 (0.6) 2.8 (0.9) 4.9 (1.4) 2.7 (1.3) 5.6 (1.5) 9.9 (2.1)
During open abdominal surgery 0.6 (0.4) 1.3 (0.2) 2.2 (1.1) 2.3 (1.6) 5.5 (1.8) 10.3 (2.5)
2–3 h after hip replacement surgery 1.0 (0.9) 2.6 (1.2) 5.1 (1.7) 2.1 (2.2) 6.0 (2.4) 11.7 (2.9)
1 day after hip replacement surgery 0.7 (0.8) 2.6 (1.3) 5.4 (2.1) 1.4 (1.6) 5.2 (1.9) 11.1 (2.6)
2 days after hysterectomy 1.3 (1.2) 4.4 (1.6) 9.0 (2.4) 1.8 (1.5) 6.1 (1.7) 12.6 (2.5)
All rates are adapted for subjects weighing 70 kg. Data are the mean (SD). Calculations begin with the actual baseline plasma glucose level of each subject
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markedly lower insulin resistance than the others (Table 1).
The disappearance rate of glucose is 10–15 % higher after
a test meal in young as compared to old men and women,
a difference that can be related mostly to insulin resistance
(Basu et al. 2006). The incidence of diabetes type 2 also
increases with age, but no such patients were included in
this compilation.
The kinetic model
The one-compartment kinetic model used here has been
criticized for being simplistic and overlooking the
endogenous glucose production, but it still offered excel-
lent curve fits in individual subjects during the vast
majority of the time period required for the glucose
disposal. One of the downsides is that higher than
modeled plasma glucose levels sometimes occur during
the first minutes after a bolus infusion (Fig. 1c). This
short “overshoot” can be studied by multi-compartment
modeling (Ferranini et al. 1985) but is of limited
relevance to the anesthetist who provides glucose as a
continuous infusion at a low speed. Another issue is that
slight hypoglycemia often develops 30–45 min after a
glucose infusion given to a subject with high insulin
sensitivity (Fig. 1a, d). This “undershoot” was not consid-
ered here and can be avoided clinically by gradual reduction
of the infusion rate.
The one-compartment model is linear for glucose
(Sjöstrand and Hahn 2003), which means that the
predicted plasma glucose concentrations become similar
regardless of whether the Vd and CL used for the simu-
lation are derived from experiments providing small or
large amounts of glucose, and regardless of whether the
infusion time is long or short. In this report, Vd was
larger for a 1-min injection compared to infusions, but
the half-life of the glucose was still quite similar regardless
of the infusion time (Table 1).
Conclusions
Computer simulations based on kinetic data from seven
studies suggested infusion rates that should be avoided
to limit the risk of hyperglycemia in the perioperative
period. Healthy volunteers can take infusion rates at
least four times higher than patients on the day of
surgery, and preoperative patients can take infusion rates
twice as high. On the day of surgery, the acceptable rates
are so low that infusing a glucose solution is hardly
meaningful. Only very small amounts of glucose and free
water can be provided at this time without imposing a
risk of hyperglycemia.
Appendix
A single-compartment kinetic model analyzed all plasma
glucose data. Here, the relationship between the rate of
infusion Ro, the volume of distribution Vd, and clearance
CL was calculated using the following differential equation








C tð Þ−Cbð Þ ð1Þ
where C is the plasma glucose at time t and Cb is the
baseline level. The solutions to this differential equation
before Eq. 2 and after Eq. 3 infusion are as follows:




C tð Þ−Cbð Þ ¼ RoCL 1−e
−CLT=Vd
 
e−CL t−Tð Þ=Vd ð3Þ
where T is the infusion time. The optimal values of Vd
and CL were estimated for each experiment separately
via a Gauss-Newton least-squares regression routine
applied to Eqs. 2 and 3, which had been entered into the
MATLAB computer program.
In the same MATLAB environment, calculations were
used to simulate the expected plasma glucose concentra-
tion at any time t in experiments not performed. The
infusion rate (Ro) needed to maintain a steady-state
concentration (Css) was obtained as
Ro ¼ CL BW  Css−Cbð Þ  0:0036 ð4Þ
where BW is the body weight (as CL is expressed per
kilo body weight), Cb is the baseline glucose concentra-
tion for a group or individual, while 0.0036 converts
mmol/min to ml/min of a glucose 5 % solution (the
molar weight for glucose of 180 g is divided by 50 mg,
which is the content of 1 ml of glucose 5 %).
The infusion rate required to reach a pre-determined
plasma concentration C(t) within a certain time t was
obtained as follows (in this study, t was set to 30 min):
Ro ¼ CL BW C tð Þ−Cbð Þ  0:00361−e−CLt=Vdð Þ ð5Þ
Equation 5 is a re-arrangement of Eq. 2 where t is
set to 30 min. Equation 4, in turn, is a special case of
Eq. 5 where the expression in the denominator
approaches 1.0.
Abbreviations
CL: clearance; HOMA-IR: homeostatic model assessment of insulin resistance;
Vd: volume of distribution.
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